发明名称 Tetrahydropyranderivater
摘要 <p>The invention concerns the compounds of formula I <CHEM> wherein the substituents have various significances, in free form and, where such forms exist, in salt form. They can be prepared by various processes, e.g. by irradiation; oxidation; elimination; reduction; conversion by e.g. halogenation or acylation; deprotection of protected hydroxy groups; protection of free hydroxy groups; and separation of stereoisomeric mixtures into individual isomers. They are indicated for use as pharmaceuticals, especially as antiinflammatory, and as antiproliferative and antiinflammatory agents.</p>
申请公布号 DK0626385(T3) 申请公布日期 2004.02.16
申请号 DK19940810297T 申请日期 1994.05.24
申请人 NOVARTIS AG 发明人 BULUSU, A. R. C. MURTY
分类号 A61K31/40;A61K9/00;A61K31/352;A61K31/357;A61K31/407;A61K31/435;A61K31/436;A61K31/445;A61P29/00;A61P35/00;A61P37/06;C07D498/12;C07D498/16;C07D498/18;C07H19/01;(IPC1-7):C07D498/18 主分类号 A61K31/40
代理机构 代理人
主权项
地址